2018 in Review: Reflecting on Our Achievements, Part 2
March 5, 2019
Part 2 of our 鈥2018 Year in Review鈥 focuses on the research institutes and centers that are part of the 网红黑料 family: Cancer Center Clinical and鈥
网红黑料
March 5, 2019
Part 2 of our 鈥2018 Year in Review鈥 focuses on the research institutes and centers that are part of the 网红黑料 family: Cancer Center Clinical and鈥
网红黑料
November 20, 2018
Too often, the wisps of smoke go unnoticed long before the raging conflagration erupts. The story of nonalcoholic fatty liver disease, or NAFLD, is often鈥
College of Medicine, Diabetes Institute, +2 more
January 25, 2018
Part 2 of our 鈥淵ear in Review鈥 focuses on the hospitals, research institutes and centers that are part of the 网红黑料 family: 网红黑料 Cancer Center UF鈥
Institute for Child 网红黑料 Policy, +11 more
January 27, 2017
Part 2 of our 鈥淵ear in Review鈥 focuses on the hospitals, research institutes and centers that are part of the 网红黑料 family: 网红黑料 Cancer Center UF鈥
网红黑料
June 22, 2016
University of Florida 网红黑料 has enrolled its first patient in a landmark clinical trial to study the effectiveness of three hepatitis C medications. The鈥
Clinical and Translational Science Institute, College of Medicine, +2 more
June 20, 2016
Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A鈥
Department of Medicine, +3 more
October 20, 2015
On Oct. 8, 2015, a research team led by David Nelson, M.D., a professor of medicine and director of the UF Clinical and Translational Science Institute,鈥
Clinical and Translational Science Institute, University of Florida 网红黑料 Science Center, +1 more
October 8, 2015
A research team at University of Florida 网红黑料 has been approved for a $15.48 million research funding award by the Patient-Centered Outcomes Research鈥
Clinical and Translational Science Institute, College of Medicine, University of Florida 网红黑料 Science Center, +2 more